Skip to main content

Urinary heme oxygenase-1 as a new and early marker of diabetic nephropathy

Research Authors
Zeinab A. Abd El-Hameed, Ghada Mohamed Saied
Research Date
Research File
Research Journal
Al-Azhar Assiut Medical Journal
Research Vol
17
Research Year
2019
Research_Pages
259–263
Research Abstract

Introduction
Microalbuminuria is considered an early marker of glomerular injury in patients with
diabetes, but tubular injury can precede glomerular injury and cannot be detected
by microalbumin. We need a new and early marker of kidney injury in
normoalbuminuric diabetic patients. Urinary heme oxygenase-1 (uHO-1) is an
enzyme that is produced in tubules in response to oxidative stress and can be a
marker of tubular injury.
Aim
To investigate the clinical implication of uHO-1 as an early diagnostic marker in
diabetic nephropathy (DN).
Patients and methods
A total of 65 diabetic patients, comprising 20 microalbuminuric patients and 45
normoalbuminuric patients, and 20 healthy participants as a control group were
included in this study. Level of uHO-1 was detected by enzyme-linked
immunosorbent assay.
Results
uHO-1 was highly significantly elevated (P<0.000) in microalbuminuric group
compared with normoalbuminuric group and control group, respectively.
Normoalbuminuric group was highly significantly elevated (P<0.000) in uHO-1
compared with the control group. uHO-1 was positively correlated with
albumin–creatinine ratio but was not correlated with estimated glomerular
filtration rate. Receiver operating characteristic curve analysis of uHO-1 levels
for early diagnosis of DN revealed that the cutoff value of uHO-1 was 5.8 ng/ml
(sensitivity 80% and specificity 71%) for early diagnosis of DN.
Conclusion
The findings of this study indicate that elevated levels of uHO-1 can be detected in
normoalbuminuric diabetic patients and revealed renal tubular damage. uHO-1
may be used as an early biomarker for DN.